Quality of Life Research

, Volume 13, Issue 8, pp 1489–1493 | Cite as

Development and Testing of the Japanese Version of the Migraine-Specific Quality of Life Instrument

  • Sadayoshi Ohbu
  • Hisaka Igarashi
  • Hiroyuki Okayasu
  • Fumihiko Sakai
  • Joseph Green
  • Richard F Heller
  • Shunichi Fukuhara
  • Donald L. Patrick
Article

Abstract

We developed and tested a version of the migraine-specific quality of life (MSQOL) instrument for use in Japan. The MSQOL was translated into Japanese, evaluated by physicians and nurses who has experienced migraine headaches, "backtranslated", approved by the author of the original version, and tested in 70 outpatients with migraine. There were no ceiling or floor effects. All three subscales were found to be internally consistent:α≥ 0.76. The patients' scores were similar to those reported in the user's manual, with the exception of a difference of about 11 points on the Avoidance Behaviors subscale. Some correlations between MSQOL scores and SF-36 scores were statistically significant, although none exceeded 0.52. Linear associations between some measures of symptoms and some MSQOL scales were statistically significant, but those associations were consistent neither for the two kinds of symptom reports (severity and frequency) nor across all MSQOL subscales. Low MSQOL scores in early 1999 correlated with more return visits for medication and with greater amounts of triptan (anti-migraine) medication in 2001 and 2002. Overall, we interpret these results as indicating that, while they cannot be used as substitutes for reports of symptoms, scores on the Japanese version of the MSQOL can be used to assess the impact of migraine headaches on patients' lives.

Headache Migraine Quality of life (QOL) 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sakai F, Igarashi H. Prevalence of migraine in Japan: A nationwide survey. Cephalalgia 1997; 17: 15–22.Google Scholar
  2. 2.
    Wagner TH, Patrick DL, Galer BS, Berzon RA. A new instrument to assess the long-term quality of life effects from migraine: Development and psychometric testing of the MSQOL. Headache 1996; 36: 484–492.Google Scholar
  3. 3.
    Patrick DL, Hurst BC, Hughes J. Further development and testing of the migraine-specific quality of life (MSQOL) measure. Headache 2000; 40: 550–560.Google Scholar
  4. 4.
    Patrick DL. The MSQOL: A quality-of-life measure for persons with migraine. User's manual and scoring diskette. US version. Available from the Medical Outcomes Trust (Medical Outcomes Trust, PMB #503, 198 Tremont Street, Boston, MA, 02116-4705, USA).Google Scholar
  5. 5.
    Patrick D, Wild D, Johnson E, Wagner T, Martin M. Cross-cultural validation of quality-of-life measures. In: Orley J, Kuyken W (eds), Quality of Life Assessment: International Perspectives. Berlin: Springer-Verlag, 1994: 19–32.Google Scholar
  6. 6.
    Bullinger M, Alonso J, Apolone G, et al. for the IQOLA project group. Translating Health Status Questionnaires and Evaluating Their Quality: The IQOLA Project Approach. J Clin Epidemiol 1998; 51: 913–923.Google Scholar
  7. 7.
    Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (Suppl 7): 1–96.Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Sadayoshi Ohbu
    • 1
  • Hisaka Igarashi
    • 2
  • Hiroyuki Okayasu
    • 3
  • Fumihiko Sakai
    • 2
  • Joseph Green
    • 4
  • Richard F Heller
    • 5
  • Shunichi Fukuhara
    • 6
  • Donald L. Patrick
    • 7
  1. 1.Department of NeurologyYokohama Municipal Citizen's HospitalYokohama (E-mail:
  2. 2.Department of MedicineKitasato UniversityJapan
  3. 3.Division of NeurologySt. Luke's International HospitalJapan
  4. 4.Graduate School of MedicineUniversity of TokyoJapan
  5. 5.School of Epidemiology and Health Sciences, School of MedicineUniversity of ManchesterUK
  6. 6.Department of Epidemiology and Health Care ResearchKyoto University Graduate School of Medicine and Public HealthJapan
  7. 7.University of WashingtonUSA

Personalised recommendations